Literature DB >> 23115291

Crystal structure of the cowpox virus-encoded NKG2D ligand OMCP.

Eric Lazear1, Lance W Peterson, Chris A Nelson, Daved H Fremont.   

Abstract

The NKG2D receptor is expressed on the surface of NK, T, and macrophage lineage cells and plays an important role in antiviral and antitumor immunity. To evade NKG2D recognition, herpesviruses block the expression of NKG2D ligands on the surface of infected cells using a diverse repertoire of sabotage methods. Cowpox and monkeypox viruses have taken an alternate approach by encoding a soluble NKG2D ligand, the orthopoxvirus major histocompatibility complex (MHC) class I-like protein (OMCP), which can block NKG2D-mediated cytotoxicity. This approach has the advantage of targeting a single conserved receptor instead of numerous host ligands that exhibit significant sequence diversity. Here, we show that OMCP binds the NKG2D homodimer as a monomer and competitively blocks host ligand engagement. We have also determined the 2.25-Å-resolution crystal structure of OMCP from the cowpox virus Brighton Red strain, revealing a truncated MHC class I-like platform domain consisting of a beta sheet flanked with two antiparallel alpha helices. OMCP is generally similar in structure to known host NKG2D ligands but has notable variations in regions typically used to engage NKG2D. Additionally, the determinants responsible for the 14-fold-higher affinity of OMCP for human than for murine NKG2D were mapped to a single loop in the NKG2D ligand-binding pocket.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115291      PMCID: PMC3554055          DOI: 10.1128/JVI.01948-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  Crystal structure of the MHC class I homolog MIC-A, a gammadelta T cell ligand.

Authors:  P Li; S T Willie; S Bauer; D L Morris; T Spies; R K Strong
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

Review 2.  Roles of the NKG2D immunoreceptor and its ligands.

Authors:  David H Raulet
Journal:  Nat Rev Immunol       Date:  2003-10       Impact factor: 53.106

Review 3.  NKG2D and Related Immunoreceptors.

Authors:  Roland K Strong; Benjamin J McFarland
Journal:  Adv Protein Chem       Date:  2004

4.  Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus.

Authors:  R O Jacoby; P N Bhatt; D G Brownstein
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

5.  Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.

Authors:  S Bauer; V Groh; J Wu; A Steinle; J H Phillips; L L Lanier; T Spies
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

6.  Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein.

Authors:  Alexander Rölle; Mehrdad Mousavi-Jazi; Mikael Eriksson; Jenny Odeberg; Cecilia Söderberg-Nauclér; David Cosman; Klas Kärre; Cristina Cerboni
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

7.  Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.

Authors:  K Kärre; H G Ljunggren; G Piontek; R Kiessling
Journal:  Nature       Date:  1986 Feb 20-26       Impact factor: 49.962

Review 8.  Zoonotic poxvirus infections in humans.

Authors:  Sue Lewis-Jones
Journal:  Curr Opin Infect Dis       Date:  2004-04       Impact factor: 4.915

9.  The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions.

Authors:  Melissa B Lodoen; Gerardo Abenes; Sean Umamoto; Jeffrey P Houchins; Fenyong Liu; Lewis L Lanier
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

10.  Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells.

Authors:  Mar Valés-Gómez; Helena Browne; Hugh T Reyburn
Journal:  BMC Immunol       Date:  2003-03-14       Impact factor: 3.615

View more
  12 in total

1.  Cowpox virus encodes a protein that binds B7.1 and B7.2 and subverts T cell costimulation.

Authors:  Xiaoli Wang; Sytse J Piersma; Jabari I Elliott; John M Errico; Maria D Gainey; Liping Yang; Christopher A Nelson; Wayne M Yokoyama; Daved H Fremont
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-01       Impact factor: 11.205

2.  Integrating Structural Information to Study the Dynamics of Protein-Protein Interactions in Cells.

Authors:  Bo Wang; Zhong-Ru Xie; Jiawen Chen; Yinghao Wu
Journal:  Structure       Date:  2018-08-30       Impact factor: 5.006

3.  A reengineered common chain cytokine augments CD8+ T cell-dependent immunotherapy.

Authors:  Anirban Banerjee; Dongge Li; Yizhan Guo; Zhongcheng Mei; Christine Lau; Kelly Chen; John Westwick; Jeffery B Klauda; Adam Schrum; Eric R Lazear; Alexander S Krupnick
Journal:  JCI Insight       Date:  2022-05-23

Review 4.  Cowpox virus employs a two-pronged strategy to outflank MHCI antigen presentation.

Authors:  William H McCoy; Xiaoli Wang; Wayne M Yokoyama; Ted H Hansen; Daved H Fremont
Journal:  Mol Immunol       Date:  2013-01-10       Impact factor: 4.407

5.  Targeting of IL-2 to cytotoxic lymphocytes as an improved method of cytokine-driven immunotherapy.

Authors:  Eric Lazear; Reza Ghasemi; Sarah M Hein; John Westwick; Dan Watkins; Daved H Fremont; Alexander Sasha Krupnick
Journal:  Oncoimmunology       Date:  2017-01-10       Impact factor: 8.110

6.  Molluscum contagiosum virus MC80 sabotages MHC-I antigen presentation by targeting tapasin for ER-associated degradation.

Authors:  Ian B Harvey; Xiaoli Wang; Daved H Fremont
Journal:  PLoS Pathog       Date:  2019-04-29       Impact factor: 6.823

Review 7.  Interleukin 2-Based Fusion Proteins for the Treatment of Cancer.

Authors:  Alana MacDonald; T-C Wu; Chien-Fu Hung
Journal:  J Immunol Res       Date:  2021-11-08       Impact factor: 4.818

8.  Retargeting IL-2 Signaling to NKG2D-Expressing Tumor-Infiltrating Leukocytes Improves Adoptive Transfer Immunotherapy.

Authors:  Anirban Banerjee; Dongge Li; Yizhan Guo; Bayan Mahgoub; Lea Paragas; Jacqueline Slobin; Zhongcheng Mei; Amir Manafi; Atsushi Hata; Kang Li; Lei Shi; John Westwick; Craig Slingluff; Eric Lazear; Alexander Sasha Krupnick
Journal:  J Immunol       Date:  2021-06-21       Impact factor: 5.422

9.  Selective targeting of IL-2 to NKG2D bearing cells for improved immunotherapy.

Authors:  Reza Ghasemi; Eric Lazear; Xiaoli Wang; Saeed Arefanian; Alexander Zheleznyak; Beatriz M Carreno; Ryuji Higashikubo; Andrew E Gelman; Daniel Kreisel; Daved H Fremont; Alexander Sasha Krupnick
Journal:  Nat Commun       Date:  2016-09-21       Impact factor: 14.919

10.  Downregulation of HLA-I by the molluscum contagiosum virus mc080 impacts NK-cell recognition and promotes CD8+ T-cell evasion.

Authors:  Hana Elasifer; Eddie C Y Wang; Virginie Prod'homme; James Davies; Simone Forbes; Richard J Stanton; Mihil Patel; Ceri A Fielding; Dawn Roberts; James A Traherne; Nicole Gruber; Joachim J Bugert; Rebecca J Aicheler; Gavin W G Wilkinson
Journal:  J Gen Virol       Date:  2020-08       Impact factor: 5.141

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.